Estadístiques de Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea
Visites totals
| views | |
|---|---|
| Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea | 92 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 6 |
| September 2024 | 6 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| Alvarez_can_real.pdf(legacy) | 191 |
| Alvarez_can_real.pdf | 2 |
Vistes principals per país
| views | |
|---|---|
| United States | 51 |
| Spain | 14 |
| Sweden | 14 |
| Germany | 5 |
| Australia | 2 |
| China | 2 |
| Israel | 1 |
| Portugal | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 14 |
| Boardman | 8 |
| Ann Arbor | 7 |
| Barcelona | 7 |
| Córdoba | 5 |
| Menlo Park | 5 |
| Potsdam | 5 |
| Fairfield | 4 |
| Madrid | 2 |
| Mountain View | 2 |
| Andover | 1 |
| Ashburn | 1 |
| Dallas | 1 |
| Dearborn | 1 |
| Porto | 1 |
| Rochester | 1 |